Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-18

Clinical Trial Update: Safety and Performance of the SPINEVISION Hexanium ACIF in the Treatment of Cervical Spine Degenerative Disc Disease

View source ↗

Summary

The document provides a trial update on the safety and performance of SPINEVISION Hexanium ACIF for cervical spine degenerative disc disease. The study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SPINEVISION Hexanium ACIF

Snippet

Sponsor: SPINEVISION SAS | Conditions: Intervertebral Disc Degeneration | Status: ACTIVE_NOT_RECRUITING